{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T03:47:36Z","timestamp":1789444056137,"version":"build-2803163510"},"reference-count":68,"publisher":"American Society for Microbiology","issue":"8","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Vaccine Immunol"],"published-print":{"date-parts":[[2008,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Vaccination with P13, a peptide mimotope of the cryptococcal capsular polysaccharide glucuronoxylomannan (GXM), has been shown to confer protection against a subsequent lethal<jats:italic>Cryptococcus neoformans<\/jats:italic>challenge. In this study, we sought to investigate whether P13-based vaccines could be effective in an already-established infection. To address this question, we developed a systemic chronic cryptococcal infection model. We vaccinated chronically infected mice with P13-protein conjugates and monitored their survival. Compared to the controls, the conjugates prolonged the survival of chronically infected mice. The degree of protection was a function of the mouse strain (BALB\/c or C57BL\/6), the carrier protein (tetanus toxoid or diphtheria toxoid), and the route of infection (intraperitoneal or intravenous). Serum GXM levels were correlated with the day of death, but the correlation was driven by the carrier protein and mouse strain. The passive transfer of heat-treated sera from P13 conjugate-vaccinated mice conferred protection to nai\u0308ve BALB\/c mice, indicating that antibody immunity could contribute to protection. The measurement of peripheral blood cytokine (gamma interferon [IFN-\u03b3], interleukin-10 [IL-10], and IL-6) gene expression showed that P13 conjugate-vaccinated BALB\/c and C57BL\/6 mice mounted a strong Th2 (IL-10)-like response relative to the Th1 (IFN-\u03b3)-like response, with the degree depending on the mouse strain and carrier protein. Taken together, our data suggest that a vaccine could hold promise in the setting of chronic cryptococcosis, and that vaccine efficacy could depend on immunomodulation and augmentation of the natural immune response of the host.<\/jats:p>","DOI":"10.1128\/cvi.00130-08","type":"journal-article","created":{"date-parts":[[2008,6,5]],"date-time":"2008-06-05T01:18:58Z","timestamp":1212628738000},"page":"1176-1187","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":42,"title":["Therapeutic Efficacy of a Conjugate Vaccine Containing a Peptide Mimotope of Cryptococcal Capsular Polysaccharide Glucuronoxylomannan"],"prefix":"10.1128","volume":"15","author":[{"given":"Kausik","family":"Datta","sequence":"first","affiliation":[{"name":"Department of Microbiology and Immunology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Lees","sequence":"additional","affiliation":[{"name":"Biosynexus Inc., 9119 Gaither Road, Gaithersburg, Maryland 20877"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liise-anne","family":"Pirofski","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology"},{"name":"Department of Medicine, Albert Einstein College of Medicine, Bronx, New York 10461"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1086\/314953","volume":"180","year":"1999","unstructured":"Abadi, J., and L. Pirofski. 1999. Antibodies reactive with the cryptococcal capsular polysaccharide glucuronoxylomannan are present in sera from children with and without human immunodeficiency virus infection. J. Infect. Dis.180:915-919.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/j.1348-0421.2000.tb02573.x","volume":"44","year":"2000","unstructured":"Abe, K., J. Kadota, Y. Ishimatsu, T. Iwashita, K. Tomono, K. Kawakami, and S. Kohno. 2000. Th1-Th2 cytokine kinetics in the bronchoalveolar lavage fluid of mice infected with Cryptococcus neoformans of different virulences. Microbiol. Immunol.44:849-855.","journal-title":"Microbiol. Immunol."},{"key":"e_1_3_2_4_2","first-page":"1","volume":"1","year":"2000","unstructured":"Aberg, J. A., J. Watson, M. Segal, and L. W. Chang. 2000. Clinical utility of monitoring serum cryptococcal antigen (sCRAG) titers in patients with AIDS-related cryptococcal disease. HIV. Clin. Trials1:1-6.","journal-title":"HIV. Clin. Trials"},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/mmy.39.1.51.67","volume":"39","year":"2001","unstructured":"Banerjee, U., K. Datta, T. Majumdar, and K. Gupta. 2001. Cryptococcosis in India: the awakening of a giant? Med. Mycol.39:51-67.","journal-title":"Med. Mycol."},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1086\/374800","volume":"187","year":"2003","unstructured":"Batzloff, M. R., W. A. Hayman, M. R. Davies, M. Zeng, S. Pruksakorn, E. R. Brandt, and M. F. Good. 2003. Protection against group A streptococcus by immunization with J8-diphtheria toxoid: contribution of J8- and diphtheria toxoid-specific antibodies to protection. J. Infect. Dis.187:1598-1608.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.10.6445-6455.2001"},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/clinids\/6.5.619","volume":"6","year":"1984","unstructured":"Bhattacharjee, A. K., J. E. Bennett, and C. P. J. Glaudemans. 1984. Capsular polysaccharides of Cryptococcus neoformans. Rev. Infect. Dis.6:619-624.","journal-title":"Rev. Infect. Dis."},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.63.4.1218-1222.1995"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.73.8.4530-4538.2005"},{"key":"e_1_3_2_11_2","unstructured":"Cryptococcus neoformans. 1998"},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/nrmicro732","volume":"1","year":"2003","unstructured":"Casadevall, A., and L. A. Pirofski. 2003. The damage-response framework of microbial pathogenesis. Nat. Rev. Microbiol.1:17-24.","journal-title":"Nat. Rev. Microbiol."},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2174\/1566524054022567","volume":"5","year":"2005","unstructured":"Casadevall, A., and L. A. Pirofski. 2005. Insights into mechanisms of antibody-mediated immunity from studies with Cryptococcus neoformans. Curr. Mol. Med.5:421-433.","journal-title":"Curr. Mol. Med."},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1378\/chest.129.2.333","volume":"129","year":"2006","unstructured":"Chang, W. C., C. Tzao, H. H. Hsu, S. C. Lee, K. L. Huang, H. J. Tung, and C. Y. Chen. 2006. Pulmonary cryptococcosis: comparison of clinical and radiographic characteristics in immunocompetent and immunocompromised patients. Chest129:333-340.","journal-title":"Chest"},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/rheumatology\/kel343","volume":"46","year":"2007","unstructured":"Chen, H. S., W. P. Tsai, H. S. Leu, H. H. Ho, and L. B. Liou. 2007. Invasive fungal infection in systemic lupus erythematosus: an analysis of 15 cases and a literature review. Rheumatology (Oxford)46:539-544.","journal-title":"Rheumatology (Oxford)"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.65.7.2599-2605.1997"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.59.1.59-64.1991"},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1365-2567.2004.01970.x","volume":"113","year":"2004","unstructured":"Chiapello, L. S., J. L. Baronetti, M. P. Aoki, S. Gea, H. Rubinstein, and D. T. Masih. 2004. Immunosuppression, interleukin-10 synthesis and apoptosis are induced in rats inoculated with Cryptococcus neoformans glucuronoxylomannan. Immunology113:392-400.","journal-title":"Immunology"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.67.6.3096-3107.1999"},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1567-1364.2006.00073.x","volume":"6","year":"2006","unstructured":"Datta, K., and L. A. Pirofski. 2006. Towards a vaccine for Cryptococcus neoformans: principles and caveats. FEMS Yeast Res.6:525-536.","journal-title":"FEMS Yeast Res."},{"key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1365-3083.1984.tb01004.x","volume":"20","year":"1984","unstructured":"Donnenberg, A. D., G. J. Elfenbein, and G. W. Santos. 1984. Secondary immunization with a protein antigen (tetanus toxoid) in man. Characterization of humoral and cell-mediated regulatory events. Scand. J. Immunol.20:279-289.","journal-title":"Scand. J. Immunol."},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1371\/journal.pmed.0040021","volume":"4","year":"2007","unstructured":"Dromer, F., S. Mathoulin-Pelissier, O. Launay, and O. Lortholary. 2007. Determinants of disease presentation and outcome during cryptococcosis: the CryptoA\/D study. PLoS. Med.4:e21.","journal-title":"PLoS. Med."},{"key":"e_1_3_2_23_2","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1021\/ac60111a017","volume":"28","year":"1956","unstructured":"Dubois, M., K. A. Giles, J. K. Hamilton, P. A. Rebers, and F. Smith. 1956. Colorimetric method for determination of sugars and related substances. Anal. Chem.28:350-358.","journal-title":"Anal. Chem."},{"key":"e_1_3_2_24_2","doi-asserted-by":"crossref","first-page":"790","DOI":"10.4049\/jimmunol.158.2.790","volume":"158","year":"1997","unstructured":"Feldmesser, M., and A. Casadevall. 1997. Effect of serum IgG1 to Cryptococcus neoformans glucuronoxylomannan on murine pulmonary infection. J. Immunol.158:790-799.","journal-title":"J. Immunol."},{"key":"e_1_3_2_25_2","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.4049\/jimmunol.166.2.1087","volume":"166","year":"2001","unstructured":"Fleuridor, R., A. Lees, and L. Pirofski. 2001. A cryptococcal capsular polysaccharide mimotope prolongs the survival of mice with Cryptococcus neoformans infection. J. Immunol.166:1087-1096.","journal-title":"J. Immunol."},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.37.10.3204-3209.1999"},{"key":"e_1_3_2_27_2","doi-asserted-by":"crossref","first-page":"E66","DOI":"10.1542\/peds.107.5.e66","volume":"107","year":"2001","unstructured":"Goldman, D. L., H. Khine, J. Abadi, D. L. Lindenberg, L. Pirofski, R. Niang, and A. Casadevall. 2001. Serologic evidence for Cryptococcus neoformans infection in early childhood. Pediatrics107:E66.","journal-title":"Pediatrics"},{"key":"e_1_3_2_28_2","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1172\/JCI116298","volume":"91","year":"1993","unstructured":"Granoff, D. M., P. G. Shackelford, S. J. Holmes, A. H. Lucas, et al. 1993. Variable region expression in the antibody responses of infants vaccinated with Haemophilus influenzae type b polysaccharide-protein conjugates. Description of a new lambda light chain-associated idiotype and the relation between idiotype expression, avidity, and vaccine formulation. J. Clin. Investig.91:788-796.","journal-title":"J. Clin. Investig."},{"key":"e_1_3_2_29_2","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1086\/322787","volume":"184","year":"2001","unstructured":"Grinsell, M., L. C. Weinhold, J. E. Cutler, Y. Han, and T. R. Kozel. 2001. In vivo clearance of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans: a critical role for tissue macrophages. J. Infect. Dis.184:479-487.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00139-06"},{"key":"e_1_3_2_31_2","doi-asserted-by":"crossref","first-page":"e128","DOI":"10.1086\/344467","volume":"35","year":"2002","unstructured":"Jenny-Avital, E. R., and M. Abadi. 2002. Immune reconstitution cryptococcosis after initiation of successful highly active antiretroviral therapy. Clin. Infect. Dis.35:e128-e133.","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_2_32_2","first-page":"123","volume":"13","year":"1996","unstructured":"Kawakami, K., M. Tohyama, K. Teruya, N. Kudeken, Q. Xie, and A. Saito. 1996. Contribution of interferon-gamma in protecting mice during pulmonary and disseminated infection with Cryptococcus neoformans. FEMS Immunol. Med. Microbiol.13:123-130.","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"e_1_3_2_33_2","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ijid.2004.12.004","volume":"10","year":"2006","unstructured":"Kiertiburanakul, S., S. Wirojtananugoon, R. Pracharktam, and S. Sungkanuparph. 2006. Cryptococcosis in human immunodeficiency virus-negative patients. Int. J. Infect. Dis.10:72-78.","journal-title":"Int. J. Infect. Dis."},{"key":"e_1_3_2_34_2","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1080\/08830180213274","volume":"21","year":"2002","unstructured":"Koguchi, Y., and K. Kawakami. 2002. Cryptococcal infection and Th1-Th2 cytokine balance. Int. Rev. Immunol.21:423-438.","journal-title":"Int. Rev. Immunol."},{"key":"e_1_3_2_35_2","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1086\/515329","volume":"177","year":"1998","unstructured":"Lendvai, N., A. Casadevall, Z. Liang, D. L. Goldman, J. Mukherjee, and L. Zuckier. 1998. Effect of immune mechanisms on the pharmacokinetics and organ distribution of cryptococcal polysaccharide. J. Infect. Dis.177:1647-1659.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_36_2","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1080\/02681219780001371","volume":"35","year":"1997","unstructured":"Li, R. K., and T. G. Mitchell. 1997. Induction of interleukin-6 mRNA in rat alveolar macrophages by in vitro exposure to both Cryptococcus neoformans and anti-C. neoformans antiserum. J. Med. Vet. Mycol.35:327-334.","journal-title":"J. Med. Vet. Mycol."},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.67.12.6314-6320.1999"},{"key":"e_1_3_2_38_2","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1097\/01.aids.0000252060.80704.68","volume":"20","year":"2006","unstructured":"Lortholary, O., G. Poizat, V. Zeller, S. Neuville, A. Boibieux, M. Alvarez, P. Dellamonica, F. Botterel, F. Dromer, and G. Chene. 2006. Long-term outcome of AIDS-associated cryptococcosis in the era of combination antiretroviral therapy. AIDS20:2183-2191.","journal-title":"AIDS"},{"key":"e_1_3_2_39_2","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1517\/13543784.16.6.787","volume":"16","year":"2007","unstructured":"Lu, M., S. Menne, D. Yang, Y. Xu, and M. Roggendorf. 2007. Immunomodulation as an option for the treatment of chronic hepatitis B virus infection: preclinical studies in the woodchuck model. Expert. Opin. Investig. Drugs16:787-801.","journal-title":"Expert. Opin. Investig. Drugs"},{"key":"e_1_3_2_40_2","unstructured":"Survival analysis: a practical approach. 2006"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.72.8.4810-4818.2004"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.72.1.196-208.2004"},{"key":"e_1_3_2_43_2","doi-asserted-by":"crossref","first-page":"4062","DOI":"10.1016\/j.vaccine.2004.03.060","volume":"22","year":"2004","unstructured":"Maitta, R. W., K. Datta, and L. A. Pirofski. 2004. Efficacy of immune sera from human immunoglobulin transgenic mice immunized with a peptide mimotope of Cryptococcus neoformans glucuronoxylomannan. Vaccine22:4062-4068.","journal-title":"Vaccine"},{"key":"e_1_3_2_44_2","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1016\/j.jinf.2006.03.018","volume":"54","year":"2007","unstructured":"Marroni, M., E. Pericolini, E. Cenci, F. Bistoni, and A. Vecchiarelli. 2007. Functional defect of natural immune system in an apparent immunocompetent patient with pulmonary cryptococcosis. J. Infect.54:e5-e8.","journal-title":"J. Infect."},{"key":"e_1_3_2_45_2","doi-asserted-by":"crossref","first-page":"4905","DOI":"10.4049\/jimmunol.171.9.4905","volume":"171","year":"2003","unstructured":"May, R. J., D. O. Beenhouwer, and M. D. Scharff. 2003. Antibodies to keyhole limpet hemocyanin cross-react with an epitope on the polysaccharide capsule of Cryptococcus neoformans and other carbohydrates: implications for vaccine development. J. Immunol.171:4905-4912.","journal-title":"J. Immunol."},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200607010-00004"},{"key":"e_1_3_2_47_2","doi-asserted-by":"crossref","first-page":"6842","DOI":"10.4049\/jimmunol.177.10.6842","volume":"177","year":"2006","unstructured":"Monari, C., T. R. Kozel, F. Paganelli, E. Pericolini, S. Perito, F. Bistoni, A. Casadevall, and A. Vecchiarelli. 2006. Microbial immune suppression mediated by direct engagement of inhibitory Fc receptor. J. Immunol.177:6842-6851.","journal-title":"J. Immunol."},{"key":"e_1_3_2_48_2","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.4049\/jimmunol.161.7.3557","volume":"161","year":"1998","unstructured":"Mukherjee, J., T. R. Kozel, and A. Casadevall. 1998. Monoclonal antibodies reveal additional epitopes of serotype D Cryptococcus neoformans capsular glucuronoxylomannan that elicit protective antibodies. J. Immunol.161:3557-3567.","journal-title":"J. Immunol."},{"key":"e_1_3_2_49_2","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1084\/jem.185.4.685","volume":"185","year":"1997","unstructured":"Nussbaum, G., W. Cleare, A. Casadevall, M. D. Scharff, and P. Valadon. 1997. Epitope location in the Cryptococcus neoformans capsule is a determinant of antibody efficacy. J. Exp. Med.185:685-694.","journal-title":"J. Exp. Med."},{"key":"e_1_3_2_50_2","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/07853890510037374","volume":"37","year":"2005","unstructured":"Pagano, L., M. Caira, and L. Fianchi. 2005. Pulmonary fungal infection with yeasts and pneumocystis in patients with hematological malignancy. Ann. Med.37:259-269.","journal-title":"Ann. Med."},{"key":"e_1_3_2_51_2","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0891-5520(02)00036-3","volume":"16","year":"2002","unstructured":"Perfect, J. R., and A. Casadevall. 2002. Cryptococcosis. Infect. Dis. Clin. N. Am.16:837-838.","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"e_1_3_2_52_2","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0966-842X(01)02134-5","volume":"9","year":"2001","unstructured":"Pirofski, L. A. 2001. Polysaccharides, mimotopes and vaccines for fungal and encapsulated pathogens. Trends Microbiol.9:445-451.","journal-title":"Trends Microbiol."},{"key":"e_1_3_2_53_2","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1053\/jinf.2000.0696","volume":"41","year":"2000","unstructured":"Powderly, W. G. 2000. Current approach to the acute management of cryptococcal infections. J. Infect.41:18-22.","journal-title":"J. Infect."},{"key":"e_1_3_2_54_2","doi-asserted-by":"crossref","first-page":"8017","DOI":"10.4049\/jimmunol.174.12.8017","volume":"174","year":"2005","unstructured":"Rivera, J., and A. Casadevall. 2005. Mouse genetic background is a major determinant of isotype-related differences for antibody-mediated protective efficacy against Cryptococcus neoformans. J. Immunol.174:8017-8026.","journal-title":"J. Immunol."},{"key":"e_1_3_2_55_2","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0923-2494(98)80751-7","volume":"149","year":"1998","unstructured":"Romani, L., and S. H. Kaufmann. 1998. Immunity to fungi: editorial overview. Res. Immunol.149:277-281.","journal-title":"Res. Immunol."},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00242-07"},{"key":"e_1_3_2_57_2","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S0891-5520(02)00043-0","volume":"16","year":"2002","unstructured":"Segal, B. H., E. J. Bow, and F. Menichetti. 2002. Fungal infections in nontransplant patients with hematologic malignancies. Infect. Dis. Clin. N. Am.16:935-964.","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"e_1_3_2_58_2","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/00006454-200206000-00013","volume":"21","year":"2002","unstructured":"Sigurdardottir, S. T., G. Ingolfsdottir, K. Davidsdottir, T. Gudnason, S. Kjartansson, K. G. Kristinsson, F. Bailleux, O. Leroy, and I. Jonsdottir. 2002. Immune response to octavalent diphtheria- and tetanus-conjugated pneumococcal vaccines is serotype- and carrier-specific: the choice for a mixed carrier vaccine. Pediatr. Infect. Dis. J.21:548-554.","journal-title":"Pediatr. Infect. Dis. J."},{"key":"e_1_3_2_59_2","first-page":"e12","volume":"46","year":"2008","unstructured":"Singh, N., B. D. Alexander, O. Lortholary, F. Dromer, K. L. Gupta, G. T. John, B. R. del, G. B. Klintmalm, J. Somani, G. M. Lyon, K. Pursell, V. Stosor, P. Munoz, A. P. Limaye, A. C. Kalil, T. L. Pruett, J. Garcia-Diaz, A. Humar, S. Houston, A. A. House, D. Wray, S. Orloff, L. A. Dowdy, R. A. Fisher, J. Heitman, M. M. Wagener, and S. Husain. 2008. Pulmonary cryptococcosis in solid organ transplant recipients: clinical relevance of serum cryptococcal antigen. Clin. Infect. Dis.46:e12-e18.","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_2_60_2","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1086\/430606","volume":"40","year":"2005","unstructured":"Singh, N., O. Lortholary, B. D. Alexander, K. L. Gupta, G. T. John, K. Pursell, P. Munoz, G. B. Klintmalm, V. Stosor, R. del Busto, A. P. Limaye, J. Somani, M. Lyon, S. Houston, A. A. House, T. L. Pruett, S. Orloff, A. Humar, L. Dowdy, J. Garcia-Diaz, A. C. Kalil, R. A. Fisher, and S. Husain. 2005. An immune reconstitution syndrome-like illness associated with Cryptococcus neoformans infection in organ transplant recipients. Clin. Infect. Dis.40:1756-1761.","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_2_61_2","doi-asserted-by":"crossref","first-page":"5509","DOI":"10.4049\/jimmunol.177.8.5509","volume":"177","year":"2006","unstructured":"Snelgrove, R. J., L. Edwards, A. E. Williams, A. J. Rae, and T. Hussell. 2006. In the absence of reactive oxygen species, T cells default to a Th1 phenotype and mediate protection against pulmonary Cryptococcus neoformans infection. J. Immunol.177:5509-5516.","journal-title":"J. Immunol."},{"key":"e_1_3_2_62_2","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0140-6736(93)90354-J","volume":"341","year":"1993","unstructured":"Spitzer, E. D., S. G. Spitzer, L. F. Freundlich, and A. Casadevall. 1993. Persistence of initial infection in recurrent Cryptococcus neoformans meningitis. Lancet341:595-596.","journal-title":"Lancet"},{"key":"e_1_3_2_63_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/13693780500088424","volume":"44","year":"2006","unstructured":"Uicker, W. C., J. P. McCracken, and K. L. Buchanan. 2006. Role of CD4+ T cells in a protective immune response against Cryptococcus neoformans in the central nervous system. Med. Mycol.44:1-11.","journal-title":"Med. Mycol."},{"key":"e_1_3_2_64_2","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1034\/j.1600-6143.2002.20701.x","volume":"2","year":"2002","unstructured":"Vilchez, R. A., J. Fung, and S. Kusne. 2002. Cryptococcosis in organ transplant recipients: an overview. Am. J. Transplant.2:575-580.","journal-title":"Am. J. Transplant."},{"key":"e_1_3_2_65_2","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1517\/14656566.6.15.2633","volume":"6","year":"2005","unstructured":"Waters, L., and M. Nelson. 2005. Cryptococcal disease and HIV infection. Expert. Opin. Pharmacother.6:2633-2644.","journal-title":"Expert. Opin. Pharmacother."},{"key":"e_1_3_2_66_2","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1021\/bc060083u","volume":"17","year":"2006","unstructured":"Xu, Q. H., X. N. Zhao, J. P. Cheng, C. H. Wei, Q. H. Zhang, and K. T. Rong. 2006. Influence of carrier proteins on the immunologic response to haptenic antitetrodotoxin vaccine. Bioconjug. Chem.17:1508-1513.","journal-title":"Bioconjug. Chem."},{"key":"e_1_3_2_67_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.73.12.8429-8432.2005"},{"key":"e_1_3_2_68_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.65.4.1158-1164.1997"},{"key":"e_1_3_2_69_2","doi-asserted-by":"crossref","first-page":"5753","DOI":"10.4049\/jimmunol.178.9.5753","volume":"178","year":"2007","unstructured":"Zhou, Q., R. A. Gault, T. R. Kozel, and W. J. Murphy. 2007. Protection from direct cerebral cryptococcus infection by interferon-gamma-dependent activation of microglial cells. J. Immunol.178:5753-5761.","journal-title":"J. Immunol."}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00130-08","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00130-08","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:42:37Z","timestamp":1684431757000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CVI.00130-08"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":68,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["10.1128\/CVI.00130-08"],"URL":"https:\/\/doi.org\/10.1128\/cvi.00130-08","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8]]},"assertion":[{"value":"2008-04-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2008-05-27","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}